As of Sep 02
| +0.19 / +7.42%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +63.64% increase from the last price of 2.75.
The current consensus among 1 polled investment analysts is to Hold stock in CorMedix Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.